Investors

Financial Report

Financial Results for FY2023

Financial Results for FY2023

3Q Results：(Apr-Dec FY2023)

Financial Results (632 KB)
Presentation Materials
Material for Financial Announcement (247 KB)
Development Pipeline Progress Status (528 KB)
Trend of Opdivo (553 KB)
Script (3.6 MB)

2Q Results：(Apr-Sep FY2023)

Financial Results (818 KB)
Presentation Materials
Material for Financial Announcement (499 KB)
Status of Cross-shareholdings (397 KB)
Development Pipeline Progress Status (534 KB)
Trend of Opdivo (553 KB)
Future Growth Strategy (768 KB)
Script (3.9 MB)

1Q Results：(Apr-Jun FY2023)

Financial Results (617 KB)
Presentation Materials
Material for Financial Announcement (297 KB)
Development Pipeline Progress Status (732 KB)
Trend of Opdivo (460 KB)
Script (8 MB)
Financial Results for FY2022

Financial Results for FY2022

Full Year Results：(Apr-Mar FY2022)

Financial Results (861 KB)
Presentation Materials
Financial Results (FY 2022) and Forecasts (FY 2023) (371 KB)
Status of Cross-shareholdings (418 KB)
Development Pipeline Progress Status (738 KB)
Trend of Opdivo (458 KB)
Script (4.7 MB)

3Q Results：(Apr-Dec FY2022)

Financial Results (639 KB)
Presentation Materials
Material for Financial Announcement (315 KB)
Development Pipeline Progress Status (695 KB)
Trend of Opdivo (458 KB)
Script (4.3 MB)

2Q Results：(Apr-Sep FY2022)

Financial Results (798 KB)
Presentation Materials
Material for Financial Announcement (375 KB)
Status of Cross-shareholdings (421 KB)
Development Pipeline Progress Status (720 KB)
Trend of Opdivo (533 KB)
Script (4.6 MB)

1Q Results：(Apr-Jun FY2022)

Financial Results (424 KB)
Presentation Materials
Material for Financial Announcement (298 KB)
Development Pipeline Progress Status (722 KB)
Trend of Opdivo (542 KB)
Script (7.2 MB)
Financial Results for FY2021

Financial Results for FY2021

Full Year Results：(Apr-Mar FY2021)

Financial Results (703 KB)
Presentation Materials
Financial Results (FY 2021) and Forecasts (FY 2022) (393 KB)
Status of Cross-shareholdings (400 KB)
Strategy for Sustainable Growth (951 KB)
Development Pipeline Progress Status (724 KB)
Trend of Opdivo (609 KB)
Script (8.5 MB)

3Q Results：(Apr-Dec FY2021)

Financial Results (648 KB)
Presentation Materials
Material for Financial Announcement (688 KB)
Development Pipeline Progress Status (1.2 MB)
Trend of Opdivo (1.2 MB)
Script (6.8 MB)

2Q Results：(Apr-Sep FY2021)

Financial Results (766 KB)
Presentation Materials
Material for Financial Announcement (841 KB)
Status of Cross-shareholdings (938 KB)
Development Pipeline Progress Status (1.2 MB)
Trend of Opdivo (1.2 MB)
Script (6.4 MB)

1Q Results：(Apr-Jun FY2021)

Financial Results (625 KB)
Presentation Materials
Material for Financial Announcement (623 KB)
Development Pipeline Progress Status (1.2 MB)
Trend of Opdivo (1.2 MB)
Script (6.7 MB)
Financial Results for FY2020

Financial Results for FY2020

Full Year Results：(Apr-Mar FY2020)

Financial Results (651 KB)
Presentation Materials
Financial Results (FY 2020) and Forecasts (FY 2021) (655 KB)
Status of Cross-shareholdings and Future Growth Investment (775 KB)
Development Pipeline Progress Status (1.3 MB)
Trend of Opdivo (1.2 MB)
Script (9 MB)

3Q Results：(Apr-Dec FY2020)

Financial Results (753 KB)
Presentation Materials
Material for Financial Announcement (681 KB)
Development Pipeline Progress Status (1.4 MB)
Trend of Opdivo (1.3 MB)
Establishment of Ono Pharma Healthcare (1 MB)
Script (1.9 MB)

2Q Results：(Apr-Sep FY2020)

Financial Results (561 KB)
Presentation Materials
Financial Results (715 KB)
Development Pipeline Progress Status (1.4 MB)
Trend of Opdivo (1.3 MB)
Script (3.4 MB)

1Q Results：(Apr-Jun FY2020)

Financial Results (343 KB)
Presentation Materials
Financial Results (635 KB)
Development Pipeline Progress Status (1.2 MB)
Trend of Opdivo (1.5 MB)
Script (2.7 MB)
Financial Results for FY2019

Financial Results for FY2019

Full Year Results：(Apr-Mar FY2019)

Financial Results (624 KB)
Presentation Materials
Financial Results (FY 2019) and Forecasts (FY 2020) (811 KB)
Development Pipeline Progress Status (1.2 MB)
Trend of Opdivo (1.4 MB)
Establishment of Ono Venture Investment, Inc. (1.1 MB)
Script (4.4 MB)

3Q Results：(Apr-Dec FY2019)

Financial Results (346 KB)
Presentation Materials
Financial Results (730 KB)
Development Pipeline Progress Status (1.1 MB)
Trend of Opdivo (854 KB)
Script (5.1 MB)

2Q Results：(Apr-Sep FY2019)

Financial Results (557 KB)
Presentation Materials
Financial Results (910 KB)
Development Pipeline Progress Status (1.9 MB)
Trend of Opdivo (982 KB)
Script (2.5 MB)

1Q Results：(Apr-Jun FY2019)

Financial Results (289 KB)
Presentation Materials
Financial Results (539 KB)
Development Pipeline Progress Status (582 KB)
Trend of Opdivo (1013 KB)
Script (3.9 MB)
Financial Results for FY2018

Financial Results for FY2018

Full Year Results：(Apr-Mar FY2018)

Financial Results (488 KB)
Presentation Materials
Financial Results (FY 2018) and Forecasts (FY 2019) (835 KB)
Ono's Initiatives in Drug Discovery (1.9 MB)
Trend of Opdivo (463 KB)
Script (10.2 MB)
Development Pipeline Progress Status (484 KB)

3Q Results：(Apr-Dec FY2018)

Financial Results (337 KB)
Presentation Materials
Financial Results (644 KB)
Overview (28 KB)
Development Pipeline Progress Status (271 KB)
Overview (17 KB)

2Q Results：(Apr-Sep FY2018)

Financial Results (487 KB)
Presentation Materials
Financial Results (140 KB)
Overview (43 KB)
Development Pipeline Progress Status (348 KB)
Overview (82 KB)

1Q Results：(Apr-Jun FY2018)

Financial Results (298 KB)
Presentation Materials
Financial Results (1.3 MB)
Overview (18 KB)
Development Pipeline Progress Status (346 KB)
Overview (24 KB)
Financial Results for FY2017

Financial Results for FY2017

Full Year Results：(Apr-Mar FY2017)

full report (343 KB)
Financial Highlights (152 KB)
Future Outlook (97 KB)
Basic policy concerning dividends and dividends for the fiscal year under review and the following fiscal year (97 KB)
Consolidated Statement of Financial Position (98 KB)
Consolidated Statement of Income (96 KB)
Consolidated Statement of Comprehensive Income (96 KB)
Consolidated Statement of Changes in Equity (98 KB)
Consolidated Statement of Cash Flows (97 KB)
Sales of Major Products (118 KB)
Revenue of Goods and Products by Geographic Area and Royalty and Other Revenue (117 KB)
Status of Development Pipeline (153 KB)
New Drugs in Development (141 KB)
Presentation Materials
Financial Results (FY 2017) and Forecasts (FY 2018) (411 KB)
Overview (47 KB)
Development Pipeline Progress Status (1.4 MB)
Overview (51 KB)
Trend of Opdivo (1.1 MB)
Overview (97 KB)

3Q Results：(Apr-Dec FY2017)

First-Third Quarter (April 1-December 31, 2017) Flash Report (unaudited) (151 KB)
Overview of Financial Results (90 KB)
Presentation Materials
Development Pipeline Progress Status (as of January 30．2018) (369 KB)
Overview (23 KB)

2Q Results：(Apr-Sep FY2017)

First-Second Quarter (April 1-September 30,2017) Flash Report (unaudited) (186 KB)
Overview of Financial Results (85 KB)
Presentation Materials
Development Pipeline Progress Status (as of November 7, 2017) (3.5 MB)
Overview (92 KB)
Trend of Opdivo (as of November 7, 2017) (409 KB)
Overview (55 KB)

1Q Results：(Apr-Jun FY2017)

First Quarter (April 1-June 30, 2017) Flash Report (unaudited) (152 KB)
Overview of Financial Results (24 KB)
Presentation Materials
Development Pipeline Progress Status (as of July 28, 2017) (380 KB)
Overview (28 KB)
Financial Results for FY2016

Financial Results for FY2016

Full Year Results：(Apr-Mar FY2016)

full report (278 KB)
Financial Highlights (32 KB)
Future Outlook (11 KB)
Basic policy concerning dividends and dividends for the fiscal year under review and the following fiscal year (12 KB)
Consolidated Statement of Financial Position (13 KB)
Consolidated Statement of Income (12 KB)
Consolidated Statement of Comprehensive Income (32 KB)
Consolidated Statement of Changes in Equity (13 KB)
Consolidated Statement of Cash Flows (13 KB)
Sales of Major Products (33 KB)
Revenue of Goods and Products by Geographic Area and Royalty and Other Revenue (32 KB)
Consolidated Statement of Income excluding the Impact of Retirement Benefits Plan Revision (12 KB)
Status of Development Pipeline (64 KB)
New Drugs in Development (35 KB)
Overview (90 KB)
Presentation Materials
Development Pipeline Progress Status (as of May 12, 2017) (961 KB)
Progress Update Discovery ＆ Research (as of May 12, 2017) (2 MB)

3Q Results：(Apr-Dec FY2016)

First-Third Quarter (April 1-December 31, 2016) Flash Report (unaudited) (152 KB)
Overview of Financial Results (36 KB)
Overview of Development Pipeline Progress Status (28 KB)
Development Pipeline Progress Status (as of January 31．2017) (344 KB)

2Q Results：(Apr-Sep FY2016)

First-Second Quarter (April 1-September 30, 2016) Flash Report (unaudited) (175 KB)
Development Pipeline Progress Status (as of October 31, 2016) (659 KB)

1Q Results：(Apr-Jun FY2016)

First Quarter (April1- June 30, 2016) Flash Report (unaudited) (327 KB)
Overview of Financial Results (100 KB)
Overview of Development Pipeline Progress Status (38 KB)
Development Pipeline Progress Status (as of Aug 2. 2016) (302 KB)
Financial Results for FY2015

Financial Results for FY2015

Full Year Results：(Apr-Mar FY2015)

full report (189 KB)
Financial Highlights (39 KB)
Management Policy (26 KB)
Consolidated Financial Forecast for the Six Months Ending September 30,2016 and for the Year Ending March 31,2017 (18 KB)
Consolidated Statement of Financial Position (20 KB)
Consolidated Statement of Income (18 KB)
Consolidated Statement of Comprehensive Income (39 KB)
Consolidated Statement of Changes in Equity (19 KB)
Consolidated Statement of Cash Flows (19 KB)
Sales of Major Products (39 KB)
Revenue of Goods and Products by Geographic Area and Royalty and Other Revenue (38 KB)
Consolidated Statement of Income excluding the Impact of Retirement Benefits Plan Revision (18 KB)
Status of Development Pipeline (76 KB)
New Drugs in Development (42 KB)
Development Pipeline Progress Status (as of May 9.2016) (381 KB)

3Q Results：(Apr-Dec FY2015)

First-Third Quarter (April 1-December 31, 2015) Flash Report (unaudited) (314 KB)
Overview of Financial Results (30 KB)
Overview of Development Pipeline Progress Status (21 KB)
Development Pipeline Progress Status (as of February 2．2016) (319 KB)

2Q Results：(Apr-Sep FY2015)

First-Second Quarter (April 1-September 30,2015) Flash Report (unaudited) (361 KB)
Overview of financial results (107 KB)
Development Pipeline Progress Status (as of October 31, 2015) (319 KB)
Overview (53 KB)

1Q Results：(Apr-Jun FY2015)

First Quarter (April 1-June 30, 2015) Flash Report (unaudited) (515 KB)
Overview of financial results (35 KB)
Overview of Development Pipeline Progress Status for 1Q of FY Ended March 31, 2016 (53 KB)
Development Pipeline Progress Status (as of Aug 4．2015) (344 KB)
Financial Results for FY2014

Financial Results for FY2014

Full Year Results：(Apr-Mar FY2014)

full report (285 KB)
Financial Highlights (40 KB)
Management Policy (24 KB)
Consolidated Financial Forecast for the Six Months Ending September 30,2015 and for the Year Ending March 31,2016 (18 KB)
Consolidated Statement of Financial Position (48 KB)
Consolidated Statement of Income (20 KB)
Consolidated Statement of Comprehensive Income (40 KB)
Consolidated Statement of Changes in Equity (27 KB)
Consolidated Statement of Cash Flows (24 KB)
Sales of Major Products (76 KB)
Status of Development Pipeline (71 KB)
New Drugs in Development (90 KB)
Presentation Materials
Development Pipeline Progress Status (as of May 13, 2015） (923 KB)
Overview (74 KB)

3Q Results：(Apr-Dec FY2014)

First-Third Quarter (April 1-December 31, 2014) Flash Report (unaudited) (232 KB)
Development Pipeline Progress Status (as of February 3, 2015) (1.2 MB)

2Q Results：(Apr-Sep FY2014)

First-Second Quarter (April 1-September 30,2014) Flash Report (unaudited) (225 KB)
Development Pipeline Progress Status (as of November 6, 2014) (1.2 MB)

1Q Results：(Apr-Jun FY2014)

First Quarter (April 1-June 30,2014) Flash Report (unaudited) (264 KB)
Development Pipeline Progress Status (as of Aug 4, 2014) (308 KB)
Financial Results for FY2013

Financial Results for FY2013

Full Year Results：(Apr-Mar FY2013)

full report (264 KB)
Financial Highlights (34 KB)
Management Policy (42 KB)
Consolidated Financial Forecast for the Six Months Ending September 30,2014 and for the Year Ending March 31,2015 (52 KB)
Consolidated Statement of Financial Position (55 KB)
Consolidated Statement of Income (52 KB)
Consolidated Statement of Comprehensive Income (73 KB)
Consolidated Statement of Changes in Equity (55 KB)
Consolidated Statement of Cash Flows (75 KB)
Notes to Consolidated Financial Statements (51 KB)
Sales of Major Products (105 KB)
Status of Development Pipeline (35 KB)
New Drugs in Development (94 KB)
Development Pipeline Progress Status (as of May 13, 2014) (315 KB)

3Q Results：(Apr-Dec FY2013)

First-Third Quarter (April 1-December 31, 2013) Flash Report (unaudited) (151 KB)
Deveploment Pipeline Progress Status (as of February 4, 2014) (311 KB)

2Q Results：(Apr-Sep FY2013)

First-Second Quarter (April 1-September 30,2013) Flash Report (unaudited) (263 KB)
Development Pipeline Progress Status (as of November 5, 2013) (383 KB)

1Q Results：(Apr-Jun FY2013)

First Quarter (April 1-June 30,2013) Flash Report (unaudited) (227 KB)
Financial Results for FY2012

Financial Results for FY2012

Full Year Results：(Apr-Mar FY2012)

full report (273 KB)
Financial Highlights (74 KB)
MANAGEMENT POLICY (42 KB)
Consolidated Financial Forecast for the Year Ending March 31,2014 (52 KB)
Consolidated Balance Sheets (56 KB)
Consolidated Statements of Income (52 KB)
Consolidated Statements of Comprehensive Income (74 KB)
Consolidated Statements of Changes in Net Asset (115 KB)
Consolidated Statements of Cash Flows (96 KB)
Notes to Consolidated Financial Statements (52 KB)
Sales of Major Products (89 KB)
Status of Development Pipeline (29 KB)
New Drugs in Development (52 KB)

3Q Results：(Apr-Dec FY2012)

First-Third Quarter (April 1-December 31, 2012) Flash Report (unaudited) (200 KB)

2Q Results：(Apr-Sep FY2012)

First-Second Quarter (April 1-September 30,2012) Flash Report (unaudited) (270 KB)

1Q Results：(Apr-Jun FY2012)

First Quarter (April 1-June 30,2012) Flash Report (unaudited) (192 KB)
Financial Results for FY2011

Financial Results for FY2011

Full Year Results：(Apr-Mar FY2011)

Flash Report (unaudited) for the year ended March 31, 2012 (188 KB)

3Q Results：(Apr-Dec FY2011)

First-Third Quarter (April 1-December 31,2011) Flash Report (unaudited) (175 KB)

2Q Results：(Apr-Sep FY2011)

First-Second Quarter (April 1-September 30,2011) Flash Report (unaudited) (128 KB)

1Q Results：(Apr-Jun FY2011)

First Quarter (April 1-June 30,2011) Flash Report (unaudited) (169 KB)
Financial Results for FY2010

Financial Results for FY2010

Full Year Results：(Apr-Mar FY2010)

Flash Report (unaudited) for the year ended March 31, 2011 (193 KB)

3Q Results：(Apr-Dec FY2010)

First - Third Quarter (April 1-December 31,2010) Flash Report (unaudited) (124 KB)

2Q Results：(Apr-Sep FY2010)

First-Second Quarter (April 1-September 30,2010) Flash Report (unaudited) (145 KB)

1Q Results：(Apr-Jun FY2010)

First Quarter (April 1-June 30,2010) Flash Report (unaudited) (124 KB)
Financial Results for FY2009

Financial Results for FY2009

Full Year Results：(Apr-Mar FY2009)

Flash Report (unaudited) for the year ended March 31,2010 (195 KB)

3Q Results：(Apr-Dec FY2009)

First-Third Quarter (April 1-December 31, 2009) Flash Report(unaudited) (103 KB)

2Q Results：(Apr-Sep FY2009)

First-Second Quarter (April 1-September 30, 2009) Flash Report(unaudited) (214 KB)

1Q Results：(Apr-Jun FY2009)

First Quarter (April 1-June 30,2009) Flash Report (unaudited) (177 KB)